Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms 99m Tc-sestamibi, 99m-Tc sestamibi, 99mTc sestamibi + [23] |
Target- |
Mechanism SPECT(Single-photon emission-computed tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (21 Dec 1990), |
Regulation- |
Molecular FormulaC36H66N6O6Tc |
InChIKeyZBTQTVSNLRPJHI-ZKPGHZHMSA-N |
CAS Registry109581-73-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Technetium Tc-99M Sestamibi Kit |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diagnostic agents | JP | 02 Apr 1993 | |
Cardiomyopathies | US | 21 Dec 1990 | |
Contrast agents | US | 21 Dec 1990 | |
Heart Diseases | CN | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Mucocutaneous Lymph Node Syndrome | Preclinical | TW | 01 Aug 2005 | |
Mucocutaneous Lymph Node Syndrome | Preclinical | TH | 01 Aug 2005 | |
Mucocutaneous Lymph Node Syndrome | Preclinical | KR | 01 Aug 2005 | |
Mucocutaneous Lymph Node Syndrome | Preclinical | CA | 01 Aug 2005 | |
Mucocutaneous Lymph Node Syndrome | Preclinical | PH | 01 Aug 2005 | |
Mucocutaneous Lymph Node Syndrome | Preclinical | BR | 01 Aug 2005 | |
Mucocutaneous Lymph Node Syndrome | Preclinical | US | 01 Aug 2005 |
Not Applicable | - | gxxgmomhtq(vahpnyrear) = ocpqoecdoq zdplhywwlw (nlpundeday ) View more | - | 01 May 2024 | |||
gxxgmomhtq(vahpnyrear) = prcpkuqdmi zdplhywwlw (nlpundeday ) View more | |||||||
Not Applicable | - | - | (Rest Study) | plxdbatsoy(krmuiecpew) = obuyzngzvx accexenwxd (tybwxkayfa, 12.6) | - | 28 Aug 2023 | |
Not Applicable | - | - | (Patients with diabetes (DB+)) | zmxixghaht(zqgjqnxrrg): HR = 1.044 (95% CI, 1.004 - 1.018), P-Value = 0.003 View more | - | 28 Aug 2023 | |
(Patients without diabetes (DB-)) | |||||||
Not Applicable | - | (Dynamic CZT-SPECT) | ughymctvwu(rixrrrwdhz) = okuzqfjlym slwichtweg (onxbgfwskj ) View more | - | 28 Aug 2023 | ||
(Conventional Gated SPECT MPI) | ughymctvwu(rixrrrwdhz) = iscvjfasfi slwichtweg (onxbgfwskj ) View more | ||||||
Phase 4 | 4 | pelyqotopf(rhczdosqhm) = xrgwosfnnj gogdvmwpan (ritdxetytm, jutktvhwxe - ymufxszwnb) View more | - | 26 Jul 2022 | |||
Not Applicable | - | - | (Women) | ipxnqxdviw(wqddzlvxwx) = omhdqmykhr syljlcqmtp (dqdwpabhyo, 14) View more | - | 18 May 2021 | |
(Men) | ipxnqxdviw(wqddzlvxwx) = hzktlnqztl syljlcqmtp (dqdwpabhyo, 11) View more | ||||||
Not Applicable | - | (Chronotropic incompetence (CI)) | mweumkignt(eewuengtvx) = mojthpuvqu zrhvafwjno (gmlnhuylkn ) View more | - | 18 May 2021 | ||
(Normal chronotropic response) | mweumkignt(eewuengtvx) = cihyqtrpoh zrhvafwjno (gmlnhuylkn ) View more | ||||||
Not Applicable | 30 | ulctxjznkb(opuimdvhql) = aaxdqvakoo dxvajfvuoz (rakodtzqgb ) | - | 28 Aug 2020 | |||
123I-BMIPP | ulctxjznkb(opuimdvhql) = ukvfwixudx dxvajfvuoz (rakodtzqgb ) | ||||||
Not Applicable | - | - | (Oncocytoma) | swbfkishpp(ciwshhxeps) = iileokzjbm rwjfpggbsb (hqktgzfwpj ) View more | - | 15 May 2020 | |
(Hybrid oncocytic/chromophobe tumor (HOCT)) | swbfkishpp(ciwshhxeps) = tuxycryqup rwjfpggbsb (hqktgzfwpj ) View more | ||||||
Not Applicable | - | (Tc-99m MIBI SPECT/CT) | (xoaqszmqdn) = Mean SUVmax and SUVR were 3.56±1.60 and 8.52±4.46 in normal parathyroid glands and significantly higher in adenoma / hyperplasia (5.80±5.04 and 14.96±13.46, p<0.05) for PHPT kwintjmidl (vjzryrocsw ) View more | - | 15 May 2020 |